Intracept Intraosseous Basivertebral Nerve Ablation
Launched by UNIVERSITY OF UTAH · Dec 13, 2022
Trial Information
Current as of January 14, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The Investigator Sponsor will initially approach patients planning to undergo the Intracept Procedure to discuss their interest in learning more about the study. With patient permission, contact information will be forwarded to a third-party research organization which will contact the patient to explain more about the study and to gather Verbal Informed Consent.
Study data will be collected by the University of Utah research staff via 4 telephone study visits under the direction of the Sponsor Investigator. The study research staff will enter the study data directly into a study database ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients scheduled for intraosseous basivertebral nerve ablation with the Intracept Procedure
- • OR Participant had an Intracept Procedure for their low back pain and completed standard of care questionnaires at their procedure appointment.
- Exclusion Criteria:
- • Not scheduled for an intraosseous basivertebral nerve ablation with the Intracept Procedure
- • Intracept procedure for different location other than low back pain
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Farmington, Utah, United States
South Jordan, Utah, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials